BioSpace News Archive

Sensient Technologies Corporation (NYSE: SXT) reported consolidated revenue of $335.8 million in this year’s second quarter compared to $323.1 million in last year’s second quarter.

Intersect ENT, Inc. today announced that it will release second quarter 2021 financial results on Friday, August 6, 2021. The Company expects to issue the release at approximately 7:00 a.m. ET and management will host a conference call at 8:30 a.m. ET.

Ocular Therapeutix, Inc. announced multiple scientific presentations at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting being held July 23-27, 2021 in Las Vegas, NV.

Ortho Clinical Diagnostics today announced it will report results for its second quarter 2021 ended July 4, 2021, after the market close on Wednesday, August 4, 2021.

Nutra Pharma Corporation announced that they have filed a new provisional patent to protect their intellectual property surrounding their development of nerve agent counter measures.

RELIEF THERAPEUTICS Holding AG reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals, Inc., has issued a press release reporting that it has validated a commercial formulation of aviptadil for intravenous use, allowing for high volume manufacture, with an anticipated one year or greater stability, under appropriate storage conditions.

Elekta announced the presentation of 36 abstracts demonstrating the technical capabilities and clinical utility of the Elekta Unity MR-Linac.

The rising prevalence of oncology indications for cancer therapeutics is projected to augment the growth of the U.S. cancer biopsy market during the forecast period, 2020 to 2030.

A recent World Health Organization study estimates that about 709 million people worldwide are suffering from otitis media.

Transfection involves the conscious introduction of nucleic acid molecules into eukaryotic cells. Some of the most common examples of transfection include introducing DNA plasmids possessing gene inserts for expression and small interfering RNA.